D Molecular Therapeutics, Inc. (NASDAQ:FDMT) is among the Best Get Rich Fast Stocks to Buy Right Now. As of December 24, 4D ...

AMD's Zen 6-based CPUs may be number crunching monsters, given their core design that is partially revealed in a performance counters document.

Background Predicting progression to aortic valve replacement (AVR) in moderate aortic stenosis (AS) is challenging. This ...

AMD Phase 3 timing, Otsuka funding to 2028, and mixed 4D-710 data with financial risk. See why FDMT stock is a hold.

Kase reports a retail supply chain shift by 2026, driven by tariffs and tech gaps, prioritizing regionalization and ...

Clinically meaningful lung function activity, measured by ppFEV1 and LCI2.5,with follow-up through 1 year at dose selected for Phase 2 Durable ...

HBO Max has released a new trailer and key art for "The Pitt" Season 2, which premieres Jan. 8 at 9 p.m. ET. New episodes of ...

EMERYVILLE, Calif., Dec. 12, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

4 analysts have shared their evaluations of 4D Molecular Therapeutics (NASDAQ:FDMT) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below offers a ...

4D Molecular Therapeutics laid off a quarter of its workforce last month with early-stage R&D bearing the brunt of the changes. The genetic medicines biotech said shrinking its headcount by 25% should ...

Abstract: Four-Dimensional Cone Beam Computed Tomography (4D-CBCT) imaging technology offers enhanced image quality and spatial resolution for intraoperative guidance, facilitating real-time tracking ...